Video Experimental Relacionado
Updated: May 6, 2026
09:06
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
2.7K
El glioma difuso de línea media mutante H3F3B p.K27I es un subtipo distinto del glioma difuso de línea media alterado
Lei Cheng1, Min Zhou2,3, Tao Luo4
1Department of Neurosurgery, Xuanwu Hospital, International Neuroscience Institute, Capital Medical University, #45 Changchun Street, Western District, Beijing, 100053, China.
Acta neuropathologica communications
|August 24, 2025
Resumen
Las mutaciones H3F3B en el glioma difuso de línea media (DMG) causan pérdida de trimetilación H3K27 y mal pronóstico. Estos tumores forman un subtipo molecular distinto con patrones de metilación únicos y frecuentes mutaciones PPM1D/ NF1.
Área de la Ciencia:
- Neuro-oncología
- Genómica del cáncer
- La epigenética
Sus antecedentes:
- El glioma difuso de línea media (DMG) es un tumor cerebral fatal con subtipos moleculares distintos.
- Los DMG alterados por H3K27 incluyen los tipos H3.3-mutante, H3.1/H3.2-mutante, EZHIP-sobreexpresante y EGFR-mutante.
- El papel de las mutaciones H3F3B en la patogénesis de la DMG y los resultados clínicos sigue sin estar claro.
Objetivo del estudio:
- Investigar las características clínicas y moleculares de los gliomas difusos de línea media mutantes H3F3B.
- Determinar el impacto de las mutaciones H3F3B en la trimetilación de H3K27 y el pronóstico del paciente.
- Delinear las características moleculares únicas y los posibles mecanismos de gliomagénesis de los DMG mutantes H3F3B.
Principales métodos:
- Recopilación retrospectiva de datos clínicos y radiológicos de 9 pacientes con DMG mutante H3F3B.
- Perfiles de metilación de ADN y secuenciación de nueva generación de muestras tumorales.
- Inmunohistoquímica para la expresión de H3K27me3 y análisis estocástico no supervisado de los datos de metilación (t-SNE).
Principales resultados:
- Todos los tumores exhibieron mutación somática H3F3B p.K27I y pérdida de expresión de H3K27me3.
- Los DMGs mutantes H3F3B formaron un grupo de metilación distinto, separado de otros gliomas de pérdida H3K27me3.
- Se observaron mutaciones frecuentes en PPM1D y NF1; el pronóstico fue pobre, comparable al de los DMG mutantes H3K27M.
Conclusiones:
- Las mutaciones H3F3B son un motor molecular distinto en el DMG, lo que lleva a la pérdida de trimetilación de H3K27 y a resultados deficientes.
- Las DMG mutantes H3F3B representan un subtipo único con metilación de ADN y perfiles mutacionales característicos.
- Estos hallazgos sugieren vías de gliogénesis divergentes entre los DMG mutantes H3F3B y los canónicos mutantes H3K27M.
Videos de Conceptos Relacionados
02:32Position-effect Variegation
5.6K
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
5.6K
02:30Histone Variants at the Centromere
4.0K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.0K
02:53Conservative Site-specific Recombination and Phase Variation
5.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.7K
02:39lncRNA - Long Non-coding RNAs
7.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K